United Plantations Bhd (2089)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 29.70 |
|---|---|
| 52-week range | 23.94 – 35.88 |
| Return, 1 month / 3 months | −8.8% / −10.0% |
| Return, 1 year / 3 years | +23.7% / +185.0% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 24.5% |
| Worst drawdown (1 year) | -17.2% |
| Average daily value traded | 22.94M MYR |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
United Plantations Bhd is a Malaysian plantation company that grows oil palms and coconuts and processes the harvest into crude palm oil, palm kernel and coconut products. Its estates and mills are located in Malaysia, and it also manages land in Indonesia through associated operations. The company serves food, oleochemical and industrial customers that use vegetable oils and coconut-derived ingredients, and it is based in Malaysia.
The shares are listed on the Bursa Malaysia in Malaysia under the code 2089, and the price on this page is in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
United Plantations Bhd (2089) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 29.70 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 212 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.7% and over the last three months it fell 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -15.2% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -10.0% | ||
| 6-month return | -6.1% | ||
| 12-month return, skipping the last month | 35.7% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.2% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 22.94M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −8.8% |
| 3 months | −10.0% |
| 6 months | −6.1% |
| 1 year | +23.7% |
| 3 years | +185.0% |
| 5 years | +267.9% |
Signals
| 50-day / 200-day average | 31.80 / 31.88 |
|---|---|
| Golden / death cross (60 days) | Death, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | MYR 0.5100 |
| 25 Nov 2025 | MYR 0.1400 |
| 25 Apr 2025 | MYR 0.2700 |
| 26 Nov 2024 | MYR 0.2000 |
| 26 Apr 2024 | MYR 0.4000 |
| 30 Nov 2023 | MYR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.